MedTrace Logo

an On-demand Program to EmpoweR Active Self-management (OPERAS)

NCT03404245 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2026-02-13

Study results available
· View outcomes & findings →

Summary

Self-management is a key component of successful chronic disease management and patients can benefit from learning about how daily activities and treatments relate to their symptoms and health status on an ongoing basis. The primary goal of this randomized controlled trial is to assess the efficacy of an e-health intervention, OPERAS, which includes two components: 1) the use of a newly developed web app to self-monitor symptoms/disease activity and treatment use, and help patients identify when a medical visit or treatment change is needed; 2) remote activity counselling provided by a physiotherapist, with the use of a wearable device (Fitbit) and the app to provide activity level feedback. The app component of OPERAS is hosted by the secure network of Arthritis Research Canada.

Conditions

Interventions

BEHAVIORAL

Education, Fitbit/self-management app, physiotherapist counselling.

Participants will receive a brief education session, use a physical activity tracker Fitbit Flex paired with a self-management app, and remote counseling by a PT. Intervention will be received immediately.

BEHAVIORAL

Same intervention with a 6 month delay

The Delayed Intervention Group will receive the same intervention as the Immediate Intervention Group, but with a 6 month delay.

Sponsors & Collaborators

  • Simon Fraser University

    collaborator OTHER

  • Arthritis Research Centre of Canada

    collaborator OTHER

  • Vancouver General Hospital

    collaborator OTHER

  • The Arthritis Society, Canada

    collaborator OTHER

  • Fraser Health

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Linda Li, PhD · Professor

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-23
Primary Completion
2022-12-30
Completion
2023-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03404245 on ClinicalTrials.gov